Secondary
Clearside Biomedical
We are a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye.
Symbol
CLSD
Last Closing Price
$10.33
Anticipated Date
TBD
Underwriters
J.P. Morgan, Cowen
To view the prospectus for Clearside Biomedical, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277